Light Intervention Therapy (LIT) then Sham LIT for Mild Cognitive Impairment
This trial will investigate the effect of a light treatment on sleep, memory and brain function in people with MCI and Alzheimer's. Light treatment may improve sleep and memory in these patients.
- Mild Cognitive Impairment
- Alzheimer's Disease
2 Primary · 8 Secondary · Reporting Duration: During waking hours for 26 weeks
2 Treatment Groups
Light Intervention Therapy (LIT) then Sham LIT
1 of 2
Sham LIT then Light Intervention Therapy
1 of 2
25 Total Participants · 2 Treatment Groups
Primary Treatment: Light Intervention Therapy (LIT) then Sham LIT · No Placebo Group · N/A
Who is running the clinical trial?
Age 50 - 85 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is senior citizens' participation encouraged in this investigation?
"Patients between 50 to 85 years of age are eligible for this clinical trial." - Anonymous Online Contributor
Which individuals are qualified to join this investigation?
"This trial is recruiting 25 adults aged between 50 and 85 who have been diagnosed with mild cognitive impairment (MCI). Besides this, they must also be amyloid beta positive according to a prior PET scan, not taking any antidepressant medications or those on antidepressants should report the drugs taken as well as dosages. Furthermore, participants need to fall in-between 0.5-4.0 and 4.5-9.0 in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB), suffer from circadian sleep disturbances while residing at home, independent living or assisted living facilities" - Anonymous Online Contributor
How many participants are involved in this experiment?
"Yes, the data hosted on clinicaltrials.gov confirms that this trial is enrolling participants. The post was published on November 1st 2022 and recently edited October 25th 2022. There are 25 openings at a single site." - Anonymous Online Contributor
What is the primary aim of this research project?
"This trial seeks to evaluate Changes in Brain Volumes over a Baseline and post-therapy time frame at Week 26. Secondary outcomes include Pittsburgh Sleep Quality Index (PSQI) Score, Circadian Stimulus (CS) values utilizing the Daysimeter device, and changes in Montreal Cognitive Assessment (MoCA) Score. The PSQI is a self-rated 19 item survey that gauges sleep quality on an interval scale of 0-3 with higher scores indicating poorer sleeping habits; The MoCA is a one page 30 point test that measures short term memory, executive functions, attention etc., it has been validated as an effective tool" - Anonymous Online Contributor